I think that the company is well over its worst. $8m of costs out, maybe more, revenue starting to grow again. 1.2x ARR.
AGM next week. Should break 20c on way to 30c.
- Forums
- ASX - By Stock
- DTC
- Ann: FY22 Results
Ann: FY22 Results, page-7
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DTC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online